Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Circulation Research | LATS1/2-CD38 Metabolic Rewiring Links Cellular Senescence to Intraplaque Thrombosis
2026-07-30
【Frontier Express】Molecular Neurodegeneration | A Multicellular Clearance Network for Passive Aβ Immunotherapy: Mechanistic Insights Beyond Plaque Removal
2026-07-29
【Frontier Express】Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology | PD-L1 inhibitor combined with EGFR monoclonal antibody significantly extends progression-free survival in advanced cutaneous squamous cell carcinoma
2026-07-29
【Frontier Express】Antibodies | Mechanistic Study of a Rationally Designed Mutant Nanobody Targeting Heparan Sulfate
2026-07-28
【Frontier Express】Nature Medicine | Innate Immune Responsiveness Determines Enhanced Cellular Immunity and Symptomatic Disease Progression after Influenza Infection
2026-07-28
【Frontier Express】Antibodies | Integrated Diagnostic Strategy for Anti-Neutrophil Antibody Testing and Immune Neutropenia
2026-07-28
【Frontier Express】Nature Medicine | Phase 1 Clinical Trial of Recombinant Rabies Virus-Vectored Lassa Vaccine in Healthy Adults
2026-07-28






